Imaxio Acquires Orphan Drug Indicated for a Congenital Metabolic Disease

News   Jan 22, 2013

 
Imaxio Acquires Orphan Drug Indicated for a Congenital Metabolic Disease
 
 
 

RELATED ARTICLES

Artificial Enzyme Can Catalyze Reactions

News

Artificial Biology has taken a step forward as a study shows the catalytic ability of a synthetic enzyme.

READ MORE

Radical New Approach to Vaccine Development Could Help Reduce Illness From Flu

News

More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help lower that figure for future flu seasons.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE